Andrew Brackin

Partner at Gradient Ventures · Joined 2024

View Live Interactive Profile →

Biography

Andrew Brackin is a Partner at Gradient Ventures investing in AI and healthcare. He co-founded Vial, a tech-enabled clinical trial platform, and was Head of Growth at Newfront (acquired by WTW in 2025). He was a Thiel Fellow in 2013 and studied entrepreneurship at Stanford.

Previous Experience

• Co-founder & CEO, Vial (clinical trial platform)
• Head of Growth, Newfront (acquired by WTW)
• Product Lead, Jobr (acquired by Monster)

Notable Investments

Sources & References